Gastrointestinal & Antiulcer

Dicyclomine Hydrochloride + ParacetamolThird Party Manufacturing in India

Looking to get Dicyclomine Hydrochloride + Paracetamol manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.

WHO-GMP Certified
Export Ready
PCD Franchise Available
CAS Number
Combination product — active constituents: Dicyclomine Hydrochloride (67-92-5), Paracetamol (103-90-2)
Drug Class
Antispasmodic + Analgesic combination
Molecular Formula
Combination — Dicyclomine HCl: C₁₉H₃₆ClNO₂; Paracetamol: C₈H₉NO₂
Molecular Weight
Combination product — Dicyclomine HCl: 345.95 g/mol; Paracetamol: 151.16 g/mol
Grade Standards
IP, BP
Therapeutic Category
Gastrointestinal & Antiulcer
MOQ
10,000 tablets per batch
Dosage Forms
Tablet

Mechanism of Action

This fixed-dose combination addresses abdominal pain and cramping through two complementary mechanisms targeting both smooth muscle spasm and central pain perception.

Dicyclomine hydrochloride relieves gastrointestinal smooth muscle spasm through a dual mechanism of action. It acts as a specific anticholinergic agent by competitively antagonizing acetylcholine at muscarinic receptor sites, with approximately one-eighth the milligram potency of atropine. This blocks parasympathetic nerve impulses that cause excessive contraction of GI smooth muscle. In addition, dicyclomine exerts a direct musculotropic effect on smooth muscle fibers by antagonizing the spasmogenic actions of bradykinin and histamine, providing antispasmodic activity independent of its anticholinergic effects. This dual action allows dicyclomine to effectively reduce both the frequency and intensity of abdominal cramps.

Paracetamol provides central analgesic and antipyretic activity. It primarily acts by inhibiting a brain-specific cyclooxygenase enzyme, reducing prostaglandin synthesis in the central nervous system. Paracetamol also activates descending serotonergic inhibitory pathways in the spinal cord and its active metabolite AM404 activates cannabinoid CB1 receptors. These central mechanisms provide effective pain relief for the visceral discomfort associated with GI disturbances.

The combination is particularly effective for painful conditions involving smooth muscle spasm where both antispasmodic and analgesic effects are needed. Paracetamol complements dicyclomine without the gastrointestinal side effects associated with NSAIDs, making this combination well-suited for patients with sensitive GI tracts.

Therapeutic Uses & Indications

Therapeutic Uses

Dicyclomine Hydrochloride + Paracetamol is indicated for the treatment of:

  • Abdominal Cramps and Colic: For symptomatic relief of painful gastrointestinal smooth muscle spasm associated with irritable bowel syndrome, gastroenteritis, and colicky abdominal pain.
  • Dysmenorrhea: For painful menstrual cramps where the antispasmodic action of dicyclomine on uterine smooth muscle combined with the central analgesic effect of paracetamol provides effective relief.
  • Functional Bowel Disorders: For patients with spastic colon or IBS who experience both abdominal pain and hypermotility without significant diarrhea.
  • Post-Surgical Abdominal Pain: For relief of cramping and pain following abdominal or gynecological surgery where smooth muscle spasm contributes to postoperative discomfort.
  • Renal Colic: As adjunctive therapy for the painful spasms associated with ureteral calculi, where smooth muscle relaxation helps reduce the intensity of colicky pain.

Why Manufacturers Choose This Combination

The Dicyclomine + Paracetamol combination occupies a valuable niche in the Indian pharmaceutical market as a non-NSAID option for abdominal pain management. This is particularly important for patients who cannot take NSAIDs due to gastritis, peptic ulcer disease, or cardiovascular concerns. Indian manufacturers produce this combination for both PCD franchise distribution and institutional supply to hospitals and nursing homes. The product enjoys steady year-round demand across general medicine, gynecology, and gastroenterology practices. Contract manufacturing of this combination benefits from readily available raw materials, simple compression tablet technology, and flexible packaging options for both domestic and export markets across Africa, Asia, and the Middle East.

Dosage Forms We Manufacture

Tablet
20mg+500mg

Frequently Asked Questions

What is the minimum order quantity for Dicyclomine Hydrochloride + Paracetamol?
Minimum order quantity for Dicyclomine Hydrochloride + Paracetamol is 10,000 tablets per batch. Please contact us for bulk pricing and custom quantities.
What dosage forms of Dicyclomine Hydrochloride + Paracetamol can you manufacture?
We manufacture Dicyclomine Hydrochloride + Paracetamol as: Tablet (20mg+500mg).
Are your manufacturing facilities WHO-GMP certified?
Yes. Celesta Healthcare works exclusively with WHO-GMP certified partner production facilities. All manufacturing batches are subject to strict quality control and documentation.
Can you manufacture Dicyclomine Hydrochloride + Paracetamol for export?
Yes. We provide export-ready Dicyclomine Hydrochloride + Paracetamol formulations structured across 25+ countries. We provide full export documentation including Certificate of Analysis (CoA), Certificate of Origin, and regulatory dossiers on request.
What grade standards do you follow for Dicyclomine Hydrochloride + Paracetamol?
We manufacture Dicyclomine Hydrochloride + Paracetamol to IP, BP pharmacopoeial standards.
Third Party Manufacturing

Get Dicyclomine Hydrochloride + Paracetamol made under your brand

  • WHO-GMP certified facilities
  • Quote within 24 hours
  • MOQ from 10,000 tablets per batch
Get a Manufacturing QuoteWhatsApp Us Now

+91 9689237122 · replies within hours

Our Manufacturing Capabilities

  • WHO-GMP Certified Partner Plants
  • 25+ years of pharma industry experience
  • PCD Franchise with monopoly rights
  • Export support across 25+ countries
  • Small batch to commercial scale
  • Custom formulation development

Packaging Options

Blister pack (Alu-Alu), Strip pack, HDPE bottle. Packaging customized to client brand guidelines.

Start Manufacturing Dicyclomine Hydrochloride + Paracetamol Today

Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Dicyclomine Hydrochloride + Paracetamol across all dosage forms. PCD franchise and export orders welcome.

Need something? Chat with us!